Joint Care
Natural health product licensed in Canada
- Other names
- Joint Care Advantage
- Licence holder
- HPI Health Products Inc.
- NPN or DIN-HM
- 80052396
- Status
- Active licence
- Licence date
- 11 July 2014
- Revision date
- 18 September 2014
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Collagène de type II non hydrolysé Source : Gallus gallus - cartilage | 30 mcg | Not calculated |
| Harpagophytum procumbens Source : Racine(s) secondaire(s) tubérisée(s) | 15 mg | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Exosquelette de crevette | 375 mg | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Sulfate de glucosamine chlorure de potassium | 375 mg | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Exosquelette de crabe | 375 mg | Not calculated |
| Salix alba Source : Écorce de racine Extraction ratio : 10:1 Dry plant equivalent : 500 mg Potency : 25 % Salicin | 50 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintaining joint health. Helps to relieve joint pain associated with osteoarthritis. Helps to protect against the deterioration of cartilage. Helps to produce and repair connective tissue.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80052396
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed. Photograph the packaging